✦ LIBER ✦

Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy

✍ Scribed by Kobayashi, Minoru; Kubo, Taro; Komatsu, Kenji; Fujisaki, Akira; Terauchi, Fumihito; Natsui, Shinsuke; Nukui, Akinori; Kurokawa, Shinsuke; Morita, Tatsuo

Book ID: 120470811
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 494 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-013-0556-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1917 PROGNOSITIC SIGNIFICANCE OF C-REACT

1917 PROGNOSITIC SIGNIFICANCE OF C-REACTIVE PROTEIN IN INTERMEDIATE-RISK JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH MOLECULAR TARGETED THERAPY

✍ Teishima, Jun; Hayashi, Tetsutaro; Seno, Yasuyuki; Ikeda, Kenichiro; Oka, Kiyota 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

1097 Prognostic factors for patients wit

1097 Prognostic factors for patients with metastatic renal cell carcinoma in the era of targeted therapy

✍ You, D.; Jeong, I.G.; Park, S.; Joung, J.Y.; Hong, J.H.; Ahn, H.; Kim, C-S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 91 KB

1775 COMPARISON OF TWO MAJOR PROGNOSTIC

1775 COMPARISON OF TWO MAJOR PROGNOSTIC MODELS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED IN THE CONTEMPORARY ERA OF TARGETED THERAPIES

✍ CRÉPEL, Maxime; Bernhard, Jean-Christophe; Joly, Florence; Ravaud, Alain; Guy, L 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 99 KB

Clinical factors associated with outcome

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to

442 ROLE OF MOLECULAR MARKERS IN NEPHREC

442 ROLE OF MOLECULAR MARKERS IN NEPHRECTOMY SPECIMEN AS PROGNOSTICATORS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE ERA OF TARGETED THERAPY

✍ You, Dalsan; Cho, Yong Mee; Lee, Jae-Lyun; Song, Cheryn; Hong, Jun Hyuk; Kim, Ch 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 139 KB

313 Role of molecular markers in nephrec

313 Role of molecular markers in nephrectomy specimen as prognosticators for patients with metastatic renal cell carcinoma in the era of targeted therapy

✍ D. You; Y.M. Cho; J.H. Ahn; D.H. Lee; J.L. Lee; J.H. Hong; C.S. Kim; H. Ahn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB